Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large-cell lymphomas.

Tabanelli V, Corsini C, Fiori S, Agostinelli C, Calleri A, Orecchioni S, Melle F, Motta G, Rotili A, Di Napoli A, Pileri SA.

Hum Pathol. 2019 May 21. pii: S0046-8177(19)30092-9. doi: 10.1016/j.humpath.2019.05.007. [Epub ahead of print]

PMID:
31125630
2.

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects.

Sapienza MR, Pileri A, Derenzini E, Melle F, Motta G, Fiori S, Calleri A, Pimpinelli N, Tabanelli V, Pileri S.

Cancers (Basel). 2019 Apr 28;11(5). pii: E595. doi: 10.3390/cancers11050595. Review.

3.

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Cascione L, Motta G, Fuligni F, Agostinelli C, Rossi M, Sapienza MR, Righi S, Broccoli A, Indio V, Melle F, Tabanelli V, Calleri A, Novero D, Facchetti F, Inghirami G, Sabattini E, Bertoni F, Pileri SA.

Mod Pathol. 2019 Apr 25. doi: 10.1038/s41379-019-0279-8. [Epub ahead of print]

PMID:
31028364
4.

Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniques.

Pileri SA, Derenzini E, Melle F, Motta G, Calleri A, Antoniotti P, Maltoni V, Spagnolo S, Fiori S, Tabanelli V, Fabbri M.

F1000Res. 2018 Dec 21;7. pii: F1000 Faculty Rev-1966. doi: 10.12688/f1000research.16755.1. eCollection 2018. Review.

5.

Diagnostic yield and predictive factors of findings in small-bowel capsule endoscopy in the setting of iron-deficiency anemia.

Olano C, Pazos X, Avendaño K, Calleri A, Ketzoian C.

Endosc Int Open. 2018 Jun;6(6):E688-E693. doi: 10.1055/a-0593-5915. Epub 2018 May 25.

6.

Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.

Orecchioni S, Talarico G, Labanca V, Calleri A, Mancuso P, Bertolini F.

Br J Cancer. 2018 May;118(10):1329-1336. doi: 10.1038/s41416-018-0076-z. Epub 2018 Apr 26.

7.

Severe esophagitis due to pinaverium bromide.

Avendaño K, Calleri A, González N.

Rev Gastroenterol Mex. 2018 Oct - Dec;83(4):455-456. doi: 10.1016/j.rgmx.2018.02.004. Epub 2018 Apr 5. English, Spanish. No abstract available.

8.

Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?

Tabanelli V, Santiago-Pacheco V, Corbellino M, Calleri A, Agostinelli C, Parravicini C, Pileri SA.

Histopathology. 2017 Mar;70(4):650-656. doi: 10.1111/his.13109. Epub 2016 Dec 20.

PMID:
27782313
9.

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

Zaja F, Tabanelli V, Agostinelli C, Calleri A, Chiappella A, Varettoni M, Luigi Zinzani P, Volpetti S, Sabattini E, Fanin R, Pileri SA.

Am J Hematol. 2017 Jan;92(1):E1-E2. doi: 10.1002/ajh.24571. Epub 2016 Nov 10. No abstract available.

10.

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.

Talarico G, Orecchioni S, Dallaglio K, Reggiani F, Mancuso P, Calleri A, Gregato G, Labanca V, Rossi T, Noonan DM, Albini A, Bertolini F.

Sci Rep. 2016 Jan 5;6:18673. doi: 10.1038/srep18673.

11.

Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case report.

Gruszka AM, Rabascio C, Cannella L, Sammassimo S, Andreola G, Gregato G, Faretta M, Calleri A, De Molfetta R, Pruneri G, Bertolini F, Alcalay M.

Sci Rep. 2015 Oct 6;5:14829. doi: 10.1038/srep14829.

12.

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.

Curigliano G, Bagnardi V, Bertolini F, Alcalay M, Locatelli MA, Fumagalli L, Rabascio C, Calleri A, Adamoli L, Criscitiello C, Viale G, Goldhirsch A.

Breast. 2015 Jun;24(3):263-71. doi: 10.1016/j.breast.2015.02.036. Epub 2015 Mar 12.

PMID:
25772326
13.

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.

Mancuso P, Calleri A, Gregato G, Labanca V, Quarna J, Antoniotti P, Cuppini L, Finocchiaro G, Eoli M, Rosti V, Bertolini F.

PLoS One. 2014 Dec 15;9(12):e114713. doi: 10.1371/journal.pone.0114713. eCollection 2014.

14.

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.

Orecchioni S, Reggiani F, Talarico G, Mancuso P, Calleri A, Gregato G, Labanca V, Noonan DM, Dallaglio K, Albini A, Bertolini F.

Int J Cancer. 2015 Mar 15;136(6):E534-44. doi: 10.1002/ijc.29193. Epub 2014 Sep 18.

15.

Paradoxic effects of metformin on endothelial cells and angiogenesis.

Dallaglio K, Bruno A, Cantelmo AR, Esposito AI, Ruggiero L, Orecchioni S, Calleri A, Bertolini F, Pfeffer U, Noonan DM, Albini A.

Carcinogenesis. 2014 May;35(5):1055-66. doi: 10.1093/carcin/bgu001. Epub 2014 Jan 13.

16.

Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan.

Cuppini L, Calleri A, Bruzzone MG, Prodi E, Anghileri E, Pellegatta S, Mancuso P, Porrati P, Di Stefano AL, Ceroni M, Bertolini F, Finocchiaro G, Eoli M.

PLoS One. 2013 Sep 12;8(9):e74345. doi: 10.1371/journal.pone.0074345. eCollection 2013.

17.

Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.

Orecchioni S, Gregato G, Martin-Padura I, Reggiani F, Braidotti P, Mancuso P, Calleri A, Quarna J, Marighetti P, Aldeni C, Pruneri G, Martella S, Manconi A, Petit JY, Rietjens M, Bertolini F.

Cancer Res. 2013 Oct 1;73(19):5880-91. doi: 10.1158/0008-5472.CAN-13-0821. Epub 2013 Aug 5.

18.

Circulating endothelial cells and circulating endothelial progenitors.

Mancuso P, Calleri A, Bertolini F.

Recent Results Cancer Res. 2012;195:163-70. doi: 10.1007/978-3-642-28160-0_14. Review.

PMID:
22527503
19.

Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.

Montagna E, Cancello G, Bagnardi V, Pastrello D, Dellapasqua S, Perri G, Viale G, Veronesi P, Luini A, Intra M, Calleri A, Rampinelli C, Goldhirsch A, Bertolini F, Colleoni M.

Clin Breast Cancer. 2012 Jun;12(3):207-14. doi: 10.1016/j.clbc.2012.03.008. Epub 2012 Apr 20.

PMID:
22520733
20.

The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression.

Martin-Padura I, Gregato G, Marighetti P, Mancuso P, Calleri A, Corsini C, Pruneri G, Manzotti M, Lohsiriwat V, Rietjens M, Petit JY, Bertolini F.

Cancer Res. 2012 Jan 1;72(1):325-34. doi: 10.1158/0008-5472.CAN-11-1739. Epub 2011 Nov 3.

21.

Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm.

Agliano A, Martin-Padura I, Marighetti P, Gregato G, Calleri A, Prior C, Redrado M, Calvo A, Bertolini F.

Clin Cancer Res. 2011 Oct 1;17(19):6163-73. doi: 10.1158/1078-0432.CCR-11-0212. Epub 2011 Aug 19.

22.

Circulating perivascular progenitors: a target of PDGFR inhibition.

Mancuso P, Martin-Padura I, Calleri A, Marighetti P, Quarna J, Rabascio C, Braidotti P, Bertolini F.

Int J Cancer. 2011 Sep 15;129(6):1344-50. doi: 10.1002/ijc.25816. Epub 2011 Apr 13.

23.

If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

Mancuso P, Calleri A, Antoniotti P, Quarna J, Pruneri G, Bertolini F.

BMC Cancer. 2010 Nov 24;10:644. doi: 10.1186/1471-2407-10-644.

24.

Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer.

Bono A, Bianchi P, Locatelli A, Calleri A, Quarna J, Antoniott P, Rabascio C, Mancuso P, Andreoni B, Bertolini F.

Cancer Biol Ther. 2010 Oct 1;10(7):682-5. Epub 2010 Oct 1.

PMID:
20676027
25.

Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.

Bertazzoni P, Rabascio C, Gigli F, Calabrese L, Radice D, Calleri A, Gregato G, Negri M, Liptrott SJ, Bassi S, Nassi L, Sammassimo S, Laszlo D, Preda L, Pruneri G, Orlando L, Martinelli G.

Leuk Lymphoma. 2010 Aug;51(8):1485-93. doi: 10.3109/10428194.2010.495799.

PMID:
20578816
26.

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

Calleri A, Bono A, Bagnardi V, Quarna J, Mancuso P, Rabascio C, Dellapasqua S, Campagnoli E, Shaked Y, Goldhirsch A, Colleoni M, Bertolini F.

Clin Cancer Res. 2009 Dec 15;15(24):7652-7657.

27.

Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype.

Biguzzi E, Mancuso P, Franchi F, Calleri A, Mancuso ME, Santagostino E, Bucciarelli P, Bertolini F, Mannucci PM.

Br J Haematol. 2009 Mar;144(5):803-5. doi: 10.1111/j.1365-2141.2008.07519.x. Epub 2008 Dec 10. No abstract available.

PMID:
19120356
28.

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

Mancuso P, Antoniotti P, Quarna J, Calleri A, Rabascio C, Tacchetti C, Braidotti P, Wu HK, Zurita AJ, Saronni L, Cheng JB, Shalinsky DR, Heymach JV, Bertolini F.

Clin Cancer Res. 2009 Jan 1;15(1):267-73. doi: 10.1158/1078-0432.CCR-08-0432. Erratum in: Clin Cancer Res. 2015 Jun 1;21(11):2652.

29.

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.

Torrisi R, Bagnardi V, Cardillo A, Bertolini F, Scarano E, Orlando L, Mancuso P, Luini A, Calleri A, Viale G, Goldhirsch A, Colleoni M.

Br J Cancer. 2008 Nov 18;99(10):1564-71. doi: 10.1038/sj.bjc.6604741. Epub 2008 Oct 21.

30.

Circulating endothelial cell number and viability are reduced by exposure to high altitude.

Mancuso P, Peccatori F, Rocca A, Calleri A, Antoniotti P, Rabascio C, Saronni L, Zorzino L, Sandri MT, Zubani A, Bertolini F.

Endothelium. 2008 Jan-Feb;15(1):53-8. doi: 10.1080/10623320802092344.

PMID:
18568945
31.

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.

Mancuso P, Colleoni M, Calleri A, Orlando L, Maisonneuve P, Pruneri G, Agliano A, Goldhirsch A, Shaked Y, Kerbel RS, Bertolini F.

Blood. 2006 Jul 15;108(2):452-9. Epub 2006 Mar 16.

32.

Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells.

Vulcano M, Dusi S, Lissandrini D, Badolato R, Mazzi P, Riboldi E, Borroni E, Calleri A, Donini M, Plebani A, Notarangelo L, Musso T, Sozzani S.

J Immunol. 2004 Nov 1;173(9):5749-56.

33.

Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.

Rabascio C, Muratori E, Mancuso P, Calleri A, Raia V, Foutz T, Cinieri S, Veronesi G, Pruneri G, Lampertico P, Iavarone M, Martinelli G, Goldhirsch A, Bertolini F.

Cancer Res. 2004 Jun 15;64(12):4373-7.

34.

Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma.

Martinelli G, Laszlo D, Bertolini F, Pastano R, Mancuso P, Calleri A, Vanazzi A, Santoro P, Cavalli F, Zucca E.

Br J Haematol. 2003 Oct;123(2):271-7.

PMID:
14531908
35.

Circulating endothelial cells as a novel marker of angiogenesis.

Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F.

Adv Exp Med Biol. 2003;522:83-97.

PMID:
12674213
36.

Unique regulation of CCL18 production by maturing dendritic cells.

Vulcano M, Struyf S, Scapini P, Cassatella M, Bernasconi S, Bonecchi R, Calleri A, Penna G, Adorini L, Luini W, Mantovani A, Van Damme J, Sozzani S.

J Immunol. 2003 Apr 1;170(7):3843-9.

38.

Evaluation of the immunomodulatory mechanisms of photochemotherapy in transplantation.

Legitimo A, Consolini R, Di Stefano R, Bencivelli W, Calleri A, Mosca F.

Transplant Proc. 2001 May;33(3):2266-8. No abstract available.

PMID:
11377523
39.

Immunological evaluation of patients with beta-thalassemia major.

Consolini R, Calleri A, Legitimo A, Massei F.

Acta Haematol. 2001;105(1):7-12.

PMID:
11340247
40.

[The hematopoietic stem cell: biology and clinical applications].

Consolini R, Legitimo A, Calleri A.

Pathologica. 2001 Feb;93(1):2-14. Review. Italian.

PMID:
11294014
41.

Distribution of age-related thymulin titres in normal subjects through the course of life.

Consolini R, Legitimo A, Calleri A, Milani M.

Clin Exp Immunol. 2000 Sep;121(3):444-7.

42.

[Description of a case of Aicardi's syndrome].

Biza M, Buzzetti R, Calleri A, Novi M, Venturelli L.

Pediatr Med Chir. 1984 Jan-Feb;6(1):161-3. Italian.

PMID:
6531238
43.

[Research on urinary elimination of reducing substances in the first and second infancy: comparison of results obtained with paper and thin layer chromatography].

Giovannini M, Consonni V, Calleri A.

Minerva Pediatr. 1965 Oct 27;17(32):1702-3. Italian. No abstract available.

PMID:
5860430
44.

[METABOLIC STUDIES IN A GROUP OF CHILDREN WITH MENTAL DEFICIENCY: URINARY ELIMINATION OF AMINO ACIDS, CARBOHYDRATES, TRYPTOPHAN METABOLITES AND ABNORMAL METABOLITES].

GIOVANNINI M, CALLERI A, TERZOLI S.

Minerva Pediatr. 1964 Mar 24;16:337-41. Italian. No abstract available.

PMID:
14147508

Supplemental Content

Loading ...
Support Center